化妆品
Search documents
两大国家级试点落户浙江金华 助力国货扬帆出海
Sou Hu Cai Jing· 2025-12-12 16:00
编辑:令文芳 (央视财经《经济信息联播》)近日,全国化妆品电子标签试点、化妆品进出口贸易便利化改革试点两 大国家级试点落户浙江金华。全国化妆品电子标签试点运行后,将大幅简化通关手续、降本提效,助力 国货扬帆出海。 转载请注明央视财经 ...
40年老牌国货眼霜,抚平细纹,水嫩眼周,好用不输大牌,买1发4抢爆了
洞见· 2025-12-12 12:37
洞见 (DJ00123987) ——不一样的观点,不一样的故事,2000万人订阅的微信大号。点击标题下蓝字"洞见"关注,我们将为您提供有价值、有意 思的延伸阅读。 品果积木专场!培养数理思维 预约直播,抢年末好礼 最近《一路繁花2》热播, 让张柏Z的风评好到爆,一颦一笑间不见疲态,状态好到根本看不出来姐今年已经45岁了。 网友直呼: " 45美成20岁,太嫩了!""震撼!果然明星就是一秒回春……" 作为骨相颜值代表,张柏Z的面部状态一直都不错。 唯独眼周,30+就逐渐出现 眼窝凹陷、眼尾下垂、泪沟眼袋、眼周皱纹 等衰老 症状 , 看起来 又老又疲惫。 但凡加班熬个夜, 大眼袋 、肿眼 泡、细纹 & 干纹立马蹬鼻子上眼, 遮瑕 + 粉底都盖不住 ,憔悴感溢出了屏幕。 更别说,长期带娃的宝妈,三班倒的姐妹 ,鱼尾纹、眉间纹、肿眼袋… … 早就在眼周组团安了家。 姐妹们, 眼周的保养越早做越好! 如果你已经出现了细纹等眼部问题 , 那就更要开始干预起来。 再强调一遍,眼霜不是智商税! 如果你觉得眼霜的效果总是差强人意,那可能是产品选错啦~ 某些中档牌子的眼霜小小一瓶, 价格可能比贵妇面霜还要高。 我自己都记不清,用 ...
12项重点任务!《化妆品企业生产质量管理体系提升三年行动计划》发布
Zhong Guo Jing Ji Wang· 2025-12-12 11:55
中国经济网12月12日讯(记者 郭文培)12月12日,国家药监局综合司发布《化妆品企业生产质量管理 体系提升三年行动计划(2026—2028年)》。该行动计划共有12项重点任务,通过开展质量体系提升行 动,到2028年底,化妆品企业主体责任意识全面增强,质量体系运行水平整体提升,企业关键岗位人员 履职能力显著提高,企业质量安全管理水平和风险防控能力持续优化,化妆品监管专业化水平不断加 强,企业负责、政府监管、行业自律、公众参与、媒体监督、法治保障的社会共治格局基本形成,化妆 品行业创新力、竞争力、品牌力明显提升。 ...
陈皮星油藤香飘第七届新会陈皮文化节!“四个共享”擘画产业新章
Nan Fang Nong Cun Bao· 2025-12-12 11:30
Core Viewpoint - The seventh Xinhui Chenpi Cultural Festival emphasizes the theme of "Xinhui Chenpi, Shared by Humanity," showcasing the high-quality development of the Xinhui Chenpi industry and establishing a significant platform for production and sales connections [2][3]. Group 1: Industry Development - The Xinhui Chenpi industry has consistently adhered to the principles of open collaboration, mutual benefit, and win-win outcomes, responding actively to national calls for East-West cooperation [10][11]. - The collaboration between Xinhui and Ningming aims to integrate Xinhui's industrial advantages with Ningming's resource endowments, creating a comprehensive industrial chain [12][13]. Group 2: Product Innovation - The "Chenpi Star Oil Vine Tea" series represents a deep integration of the industrial value of Xinhui Chenpi and the health resources of Ningming's "plant brain gold" star oil vine, based on a clear "complementary" logic [15][16]. - The collaboration has established a complete industrial chain from "Ningming planting—Bay Area empowerment—national sales," involving over 12,000 households in Ningming cultivating 60,000 acres of star oil vine, with each household potentially increasing annual income by 15,000 to 40,000 yuan [24][29]. Group 3: Collaborative Framework - The "Four Sharing" model has been innovatively constructed to enhance product quality and market access through shared research platforms, production standards, market channels, and storage resources [17][18][39]. - The collaboration has led to significant economic impacts, with a cumulative sales amount of 235 million yuan for agricultural products, and the establishment of a cooperative model involving enterprises, cooperatives, and farmers [32][24]. Group 4: Cultural and Educational Initiatives - Cultural collaboration is also deepening, with the establishment of the "Xinhui-Ningming Jing Tang Library," promoting cultural enrichment and rural civilization [34][36]. - The Xinhui Ningming work group has invited national channel merchants and entrepreneurs to explore the "Chenpi+" product development and promotion, aiming to jointly tap into the vast potential of the health industry [43][45].
丸美生物:向香港联交所递交H股发行上市申请
Hua Er Jie Jian Wen· 2025-12-12 09:40
重要提示 丸美生物H股发行上市申请公告要点解读 核心事项 申请递交:丸美生物(603983)于2025年12月11日向香港联交所递交H股发行上市申请,同日在港交所 网站刊登申请资料。 发行安排 发行对象:仅限香港公众投资者、符合条件的境外投资者、有权进行境外证券投资的境内合格投资者等 特定投资者群体。 上市地点:香港联交所主板 申请资料为草拟版本,内容可能更新修订 仍需获得中国证监会、香港证监会、港交所等监管机构批准 事项存在不确定性,不构成投资要约或邀请 信息获取 公司已提供申请资料在港交所网站的中英文查询链接,供境内投资者了解相关信息。 ...
丸美生物(603983.SH):向香港联交所递交H股发行上市的申请并刊发申请资料
Ge Long Hui A P P· 2025-12-12 09:39
格隆汇12月12日丨丸美生物(603983.SH)公布,公司已于2025年12月11日向香港联合交易所有限公司(以 下简称"香港联交所")递交了发行H股股票并在香港联交所主板挂牌上市(以下简称"本次发行上市")的申 请,并于同日在香港联交所网站刊登了本次发行上市的申请资料。 ...
化妆品板块12月12日跌0.34%,嘉亨家化领跌,主力资金净流出8756.28万元
Zheng Xing Xing Ye Ri Bao· 2025-12-12 09:12
以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 从资金流向上来看,当日化妆品板块主力资金净流出8756.28万元,游资资金净流入472.66万元,散户资 金净流入8283.61万元。化妆品板块个股资金流向见下表: 证券之星消息,12月12日化妆品板块较上一交易日下跌0.34%,嘉亨家化领跌。当日上证指数报收于 3889.35,上涨0.41%。深证成指报收于13258.33,上涨0.84%。化妆品板块个股涨跌见下表: ...
植物医生IPO之路:品牌沉淀,模式聚焦
Jiang Nan Shi Bao· 2025-12-12 07:56
Core Viewpoint - The IPO of Plant Doctor, a company focused on high-altitude plant skincare and a single-brand chain model, reflects a significant shift in the Chinese cosmetics industry towards brand value and sustainable business models after a period of intense competition and marketing frenzy [1] Group 1: Company Overview - Plant Doctor has over 30 years of experience and integrates traditional wisdom from the Naxi culture into its modern brand strategy, emphasizing "high-altitude plants for pure skin" [3] - The company has established a robust research and development network, collaborating with the Kunming Institute of Botany since 2014, and has created a global R&D network with five bases [3] - Plant Doctor has developed a core ingredient, "Dendrobium oligosaccharides," through extensive research on high-altitude plants, which has led to market success for its flagship product line [3] Group 2: Business Model - The company focuses on a single-brand chain model, maintaining over 4,200 stores globally, which enhances brand experience and customer trust [4] - This model creates significant channel control and operational efficiencies, supported by a large network that provides valuable consumer data for product development [4] - Plant Doctor has been recognized as a leading single-brand skincare store by Euromonitor International for three consecutive years, validating the effectiveness of its business model [4] Group 3: Market Context - The cosmetics industry is moving away from rapid expansion driven by traffic and price competitiveness, with increasing pressure from homogenization and profit margins [5] - Investors and consumers are now favoring brands with clear differentiation, solid technological foundations, and sustainable profit models [5] Group 4: IPO and Future Prospects - The funds raised from the IPO will be used to enhance R&D and upgrade the global store network, reinforcing the company's competitive advantages [6] - The successful expansion into markets like Japan and Thailand demonstrates the cross-cultural appeal of its "high-altitude plant" positioning and single-brand model [6] - The journey of Plant Doctor's IPO signifies a broader trend in the Chinese cosmetics industry towards high-quality development, emphasizing brand value and operational focus [6]
四川悦颜美化妆品有限公司成立 注册资本10万人民币
Sou Hu Cai Jing· 2025-12-12 07:35
天眼查App显示,近日,四川悦颜美化妆品有限公司成立,法定代表人为王义才,注册资本10万人民 币,经营范围为一般项目:化妆品零售;化妆品批发;日用品销售;日用百货销售;食品互联网销售 (仅销售预包装食品);食品销售(仅销售预包装食品);互联网销售(除销售需要许可的商品);母 婴用品销售;办公用品销售;文具用品零售。(除依法须经批准的项目外,凭营业执照依法自主开展经 营活动)许可项目:生活美容服务。(依法须经批准的项目,经相关部门批准后方可开展经营活动,具 体经营项目以相关部门批准文件或许可证件为准)。 ...
植物医生IPO闯关之路,门店突破4200家,品牌力增长引关注
Jin Tou Wang· 2025-12-12 07:28
Core Viewpoint - The IPO review status of Beijing Plant Doctor Cosmetics Co., Ltd. has been updated to "inquired," marking a critical stage in its journey to list on the Shenzhen Stock Exchange, representing a significant leap for a Chinese brand rooted in technology and culture to go global [1] Group 1: Brand Philosophy and Strategy - The brand's philosophy is deeply influenced by the wisdom of the Naxi ethnic group's herbal medicine, emphasizing the use of natural plant resources for skincare [3] - Plant Doctor has established a differentiated strategy by combining traditional high-altitude plant resources with modern skincare technology, creating a unique path for "Chinese brand, Chinese ingredients" [3] - The brand has successfully built a strong image of being natural, safe, and effective in the minds of global consumers, laying a solid foundation for market expansion [3] Group 2: Research and Development - The company has established the "Chinese Academy of Sciences Kunming Plant Research Institute Plant Doctor R&D Center," which serves as the cornerstone of its research capabilities [3] - Plant Doctor has developed a global R&D network with a structure of "one center, five bases," covering various locations including Beijing, Kunming, Shunde, Wuxi, and Tokyo, ensuring a complete closed-loop from basic research to industrial application [3] - The innovative transformation of large molecular Dendrobium polysaccharides into more absorbable Dendrobium oligosaccharides exemplifies the company's strong R&D capabilities, contributing to the success of its flagship product series with annual sales exceeding 5.8 billion yuan [5][6] Group 3: Market Presence and Sales Channels - Plant Doctor has adopted a unique channel model that deeply integrates products and services, focusing on offline chain operations rather than relying solely on online traffic [6] - As of June 2025, the company has over 4,200 single-brand stores globally, serving more than 30 million members across multiple countries and regions [6] - The brand has been recognized as a leader in the beauty and body care industry in China for three consecutive years and has received certification as a "global leader in single-brand skincare specialty stores" from Euromonitor International since 2023 [6] Group 4: Global Expansion and Corporate Responsibility - The company has made steady progress in its global expansion, with successful entries into markets such as Japan, Singapore, and Thailand, showcasing its vision of making the world love Chinese cosmetics [8] - Plant Doctor adheres to the philosophy of respecting nature, valuing science, and giving back to society, aligning its actions with the goals of the United Nations Development Programme (UNDP) [8] - The funds raised from the IPO will be used to enhance R&D innovation, upgrade brand image, and expand global marketing channels, positioning the company as a cultural ambassador and a responsible enterprise [8]